COVID-19: A Cure and Preventive Options

The world experienced the outbreaks of coronavirus infection that threaten global pandemic in 2002-2003 by Severe Acute Respiratory Syndrome (SARS) and in 2011 by Middle East Respiratory Syndrome (MERS). The genomic sequence of SARS-CoV-2 showed similar, but distinct genome composition of SARS-CoV and MERS-CoV [1,2]. On an average corona hit the 1.5% to 2020 global GDP and 0.2% to long-run global GDP. We forecast a muted longterm impact because damage to productive capacity will be small, plus economic confidence should quickly return once the virus subsides. The body’s immune system is, at the moment, the most effective weapon people have against COVID-19. The majority of patients can cure themselves of the disease simply by resting at home enabling a small army of their own cells to attack the infection. The some antiviral, anti-malarial, spiked protein based vaccine and antibody plasma therapies as a cure and phytochemical, stronger immune system and guideline given by health agencies discussed as a preventive approach discussed in this article.